drugset / Trial / NCT06730516

Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

NCT06730516

Phase 0 Completed 56 enrolled Zagazig University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aimed to evaluate the effects of topical Latanoprost 0.005 % versus Brimionidin tartrate 0.2% on perfusion of optic nerve head This prospective interventional randomized study included 56 naive patients recently diagnosed with bilateral primary open angle glaucoma equally divided into two groups with 28 patients in each group

Timeline

Start
2024-06-24
Primary completion
2024-09-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.2 % Topical
Subject Latanoprost Small molecule 0.005 % Topical

Indications